Neogen Corporation (NEOG) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from May 31 2026 to May 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neogen Corporation  (NASDAQ: NEOG)


Neogen's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Neogen's ROI in the fourth quarter of 2026?
Neogen Corporation recorded a cumulative net loss of $-8 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -0.24%.

Within the Healthcare sector 194 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the May 31 2026 quarter, so far to 3312, from total ROI ranking in the third quarter of 2026 at 3840.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (May 31 2026)
IV. Quarter		 (Feb 28 2026)
III. Quarter		 (Nov 30 2025)
II. Quarter		 (Aug 31 2025)
I. Quarter		 (May 31 2025)
IV. Quarter
Y / Y Investment Change TTM -19.06 % -23.93 % -22.32 % -15.99 % -9.69 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3,193 3,208 3,270 3,232 3,271
Return On Investment (TTM) -0.24 % -18.76 % -17.64 % -28.21 % -27.4 %
NEOG's Overall Ranking # 3312 # 3840 # 3577 # 3586 # 3211
Seq. Investment Change TTM -0.6 % -5.02 % -7.6 % -7.21 % -6.59 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -8 -609 -603 -1,043 -1,092

NEOG Company Profile >> Back to NEOG Roi Comparisons >> See Annual NEOG Return On Investment



Return On Investment NEOG's Ranking
Within: No.
Industry # 4
Sector # 195
Overall # 3312

Return On Investment Statistics
High Average Low
11.92 %
4.36 %
-28.21 %
(Aug 31 2018)   (Aug 31 2025)



  News about Neogen Corporation Return on Investment ROI

Neogen Corporation Appoints James Walter as Vice President, Global Operations to Drive Operational Excellence and Profitability

February 6, 2024

Neogen Appoints James Walter as Vice President, Global Operations
- Company aims to enhance global manufacturing and logistics functions -
LANSING, Mich., Feb. 6, 2024 - Neogen Corporation (NASDAQ: NEOG), a leading global provider of food safety and animal health solutions, announced the appointment of James Walter as the Vice President of Global Operations. With this key leadership role, the company aims to strengthen and streamline its global manufacturing and logistics functions to drive efficiency and enhance operational capabilities.
Mr. Walter brings with him a wealth of experience and expertise in operations management, having previously held executive positions in multinational companies. His strong leadership skills and deep industry knowledge make him an excellent fit for Neogen Corporation as it continues to expand its global presence.





Financial Statements
Neogen's IV. Quarter Investments $ 3,193 Millions NEOG's Balance sheet
Neogen's IV. Quarter Income $ -11 Millions Quarterly NEOG's Income Statement
NEOG's Income by Division See NEOG's Income by Division


NEOG Annual Return On Investment (May 31 2026)
2026		 (May 31 2025)
2025		 (May 31 2024)
2024		 (May 31 2023)
2023		 (May 31 2022)
2022
Total Investments in Millions 3,193 3,270 4,395 4,409 915
Y / Y Investment Growth -2.36 % -25.59 % -0.33 % 381.81 % 5.6 %
Net Income in Millions -8 -1,092 -9 -23 48
Y / Y Net Income Growth - - - - -20.65 %
Annual Return On Investment -0.25 % -33.4 % -0.21 % -0.52 % 5.28 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NEOG's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NEOG's Competitors
Subscribers only: Roi for Neogen's Suppliers
Subscribers only: Return On Investment for NEOG's Customers

Other Ratios
NEOG's Roa NEOG's Inventory Turnover Ratio NEOG's Growth Rates NEOG's Dividend Statistics
NEOG's Profitability Ratios NEOG's Asset Turnover Ratio NEOG's Dividend Growth
NEOG's Roe NEOG's Valuation Ratios NEOG's Financial Strength Ratios NEOG's Dividend Payout Ratio



Companies with similar Return On Investment at May 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T09:58:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.